Sinclair Pharma

Founded in 1971, Sinclair Pharma is a distinguished global medical aesthetics company specializing in an extensive product range designed for aesthetic and medical treatments. The company operates with a robust in-house commercial infrastructure, encompassing manufacturing capabilities, company-owned affiliates, and a strategic network of distributors across leading international markets. This integrated approach ensures efficient delivery and market penetration. Sinclair Pharma's products are currently distributed in 55 countries worldwide, underscoring its significant global footprint. In 2018, the company was acquired by Huadong Medicine Ltd, a strategic move that further solidified its position within the healthcare sector.

With a workforce of 500-1,000 employees, Sinclair Pharma maintains a significant operational scale. The company's commitment to its global presence is supported by its dedicated team, and interested parties can learn more by accessing Meet Sinclair Pharma's team. This operational infrastructure, combined with a focus on innovation in aesthetic technology, allows Sinclair Pharma to offer both invasive and complementary treatments. The company's strategic location count of 6 facilities supports its widespread distribution and operational efficiency, enabling it to serve diverse markets effectively.

Sinclair Pharma's product portfolio includes a variety of aesthetic solutions, emphasizing natural-looking results and pure-play aesthetic technology. The company serves both B2B and B2C markets, demonstrating a broad market engagement strategy. Its industry focus spans Pharmaceuticals and Healthcare, positioning it as a key player in the medical aesthetics segment. The company's revenue reached $288.6M, reflecting its substantial market presence and commercial success. Sinclair Pharma's long history, established infrastructure, and global reach make it a notable entityView more...